A pilot study on EORTC or PERCIST for the prediction of progression-free survival with nivolumab therapy in advanced or metastatic gastric cancers: A STROBE-compliant article

Recent breakthrough results from immune checkpoint inhibitors (ICIs) have paved the way to a new era of cancer immunotherapy, and have thus led to a paradigm shift of cancer treatment. In particular, inhibition of the antiprogrammed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) axis with ICI, inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakajo, Masatoyo, Kitajima, Kazuhiro, Toriihara, Akira, Arigami, Takaaki, Daisaki, Hiromitsu, Nakamura, Akira, Ohtsuka, Takao, Miwa, Hiroto, Yoshiura, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
6800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051980/
https://www.ncbi.nlm.nih.gov/pubmed/33847661
http://dx.doi.org/10.1097/MD.0000000000025494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051980/
https://www.ncbi.nlm.nih.gov/pubmed/33847661
http://dx.doi.org/10.1097/MD.0000000000025494

Ejemplares similares